[go: up one dir, main page]

SI3082798T1 - Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti - Google Patents

Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti

Info

Publication number
SI3082798T1
SI3082798T1 SI201431852T SI201431852T SI3082798T1 SI 3082798 T1 SI3082798 T1 SI 3082798T1 SI 201431852 T SI201431852 T SI 201431852T SI 201431852 T SI201431852 T SI 201431852T SI 3082798 T1 SI3082798 T1 SI 3082798T1
Authority
SI
Slovenia
Prior art keywords
hyperactivity
treatment
attention deficit
benzodioxol derivatives
benzodioxol
Prior art date
Application number
SI201431852T
Other languages
English (en)
Inventor
Marc Verleye
Veronique Riban
Guern Marie-Emmanuelle Le
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of SI3082798T1 publication Critical patent/SI3082798T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4458Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201431852T 2013-12-18 2014-12-17 Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti SI3082798T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13306768.6A EP2886116A1 (en) 2013-12-18 2013-12-18 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
PCT/EP2014/078345 WO2015091718A1 (en) 2013-12-18 2014-12-17 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
EP14828152.0A EP3082798B1 (en) 2013-12-18 2014-12-17 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity

Publications (1)

Publication Number Publication Date
SI3082798T1 true SI3082798T1 (sl) 2021-09-30

Family

ID=49883008

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431852T SI3082798T1 (sl) 2013-12-18 2014-12-17 Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti

Country Status (11)

Country Link
US (1) US20160331723A1 (sl)
EP (2) EP2886116A1 (sl)
JP (1) JP6585598B2 (sl)
CA (1) CA2933730C (sl)
DK (1) DK3082798T3 (sl)
ES (1) ES2879951T3 (sl)
HU (1) HUE054891T2 (sl)
PL (1) PL3082798T3 (sl)
PT (1) PT3082798T (sl)
SI (1) SI3082798T1 (sl)
WO (1) WO2015091718A1 (sl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795893A (fr) 1972-02-28 1973-06-18 Unicler Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique
FR2253505A2 (en) * 1973-12-10 1975-07-04 Unicler Alpha ethylenic alcohol and ketone derivs of pinacoline - modifiers of hexobarbital narcosis and anticonvulsants
FR2253503A2 (en) * 1973-12-10 1975-07-04 Unicler Ethylenic piperonal alcohols and ketones - anxiolytics, antidepressants, hypnotics and tranquillisers
JP2006517958A (ja) * 2003-02-19 2006-08-03 ニューロジェン・コーポレイション アリール酸ピリミジニルメチルアミド、ピリダジニルメチルアミドおよび関連化合物
JP2007523109A (ja) * 2004-02-18 2007-08-16 エフ.ホフマン−ラ ロシュ アーゲー 複素環式Gaba−Aサブタイプ選択的レセプターモジュレーター
AU2007346591A1 (en) * 2007-02-07 2008-08-14 Gosforth Centre (Holdings) Pty Ltd Treatment of ADHD
EP2331088A4 (en) * 2008-08-06 2011-10-12 Gosforth Ct Holdings Pty Ltd COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
ES2612115T3 (es) * 2008-12-08 2017-05-12 Biocodex Compuestos y métodos para tratar trastornos del espectro autista
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
WO2011057199A1 (en) * 2009-11-06 2011-05-12 Adenios, Inc. Compositions for treating cns disorders
EP2598478A2 (en) * 2010-07-26 2013-06-05 Neurotherapeutics Pharma, Inc. Arylsulfonamide derivatives, compositions, and methods of use

Also Published As

Publication number Publication date
US20160331723A1 (en) 2016-11-17
PT3082798T (pt) 2021-07-16
ES2879951T3 (es) 2021-11-23
JP6585598B2 (ja) 2019-10-02
JP2016540815A (ja) 2016-12-28
HUE054891T2 (hu) 2021-10-28
WO2015091718A1 (en) 2015-06-25
CA2933730A1 (en) 2015-06-25
EP2886116A1 (en) 2015-06-24
EP3082798A1 (en) 2016-10-26
PL3082798T3 (pl) 2021-11-02
DK3082798T3 (da) 2021-07-19
EP3082798B1 (en) 2021-05-05
CA2933730C (en) 2022-06-28

Similar Documents

Publication Publication Date Title
GB2513167B (en) Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
GB2516335B (en) The use of phytocannabinoids in the treatment of ovarian carcinoma
IL242610A0 (en) History of pyrazolopyrrolidine and their use in the treatment of diseases
IL242483B (en) Preparations containing omomyc and their use for cancer treatment
EP3072517A4 (en) Use of ginsenoside-rg3 in preparing medicine for preventing or/and treating dementia and medicine
PT3004108T (pt) Derivados de pirazolo-pirrolidin-4-ona como inibidores de bet e a sua utilização no tratamento de doenças
GB2509710B (en) Photobioreactor and its use in waste water treatment
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
LT3074033T (lt) Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai
SI2872176T1 (sl) Karboranilporfirin za uporabo pri zdravljenju raka
GB201308753D0 (en) Compounds and their use in therapy
HUE047636T2 (hu) Arginin csontízületi gyulladás kezelésében és/vagy megelõzésében történõ alkalmazásra
PL3082798T3 (pl) Pochodne benzodioksolu do stosowania w leczeniu deficytu uwagi i nadpobudliwości
SI3047851T1 (sl) Uporaba odiparcila za zdravljenje mukopolisaharidoze
GB201308217D0 (en) Compounds and their use in therapy
GB201314784D0 (en) Method and homeopathic remedy for treatment of the attention deficit hyperactivity disorder in children
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB201322958D0 (en) Uses of oligouronates in cancer treatment